Cargando…

A systematic review of epigenetic biomarkers in progression from non-dysplastic Barrett’s oesophagus to oesophageal adenocarcinoma

OBJECTIVES: The objective of this systematic review is to identify and summarise studies which examine epigenetic biomarkers in patients with Barrett’s oesophagus (BO) and their association with progression to oesophageal adenocarcinoma (OADC). BO is a precursor lesion for OADC. There is no clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieto, Tom, Tomlinson, Claire L, Dretzke, Janine, Bayliss, Susan, Price, Malcolm James, Dilworth, Mark, Beggs, Andrew D, Tucker, Olga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042533/ https://www.ncbi.nlm.nih.gov/pubmed/29961009 http://dx.doi.org/10.1136/bmjopen-2017-020427

Ejemplares similares

Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol
por: Nieto, T, et al.
Publicado: (2016)

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study
por: Masclee, Gwen M C, et al.
Publicado: (2015)

Endoscopic Management of Dysplastic Barrett’s Oesophagus and Early Oesophageal Adenocarcinoma
por: Eusebi, Leonardo Henry, et al.
Publicado: (2023)

Coding of Barrett’s oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study
por: Chadwick, Georgina, et al.
Publicado: (2017)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Diagnostic Inaccuracies of Barrett’s Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance?
por: Brosnan, Conor, et al.
Publicado: (2020)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

Factors influencing participation in randomised clinical trials among patients with early Barrett’s neoplasia: a multicentre interview study
por: Peerally, Mohammad Farhad, et al.
Publicado: (2023)

An Urban Center Experience Exploring Barriers to Adherence to Endoscopic Surveillance for Non-Dysplastic Barrett’s Esophagus
por: Isseh, Mahmoud, et al.
Publicado: (2021)

Fatty liver disease and the risk of erosive oesophagitis in the Korean population: a cross-sectional study
por: Choi, Ja Sung, et al.
Publicado: (2019)

Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis
por: Jiang, Yan, et al.
Publicado: (2021)

Education level and survival after oesophageal cancer surgery: a prospective population-based cohort study
por: Brusselaers, Nele, et al.
Publicado: (2013)

Mortality in gastro-oesophageal reflux disease in a population-based nationwide cohort study of Swedish twins
por: Ness-Jensen, Eivind, et al.
Publicado: (2020)

Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus
por: Cook, Michael B, et al.
Publicado: (2016)

Dietary antioxidant intake and the risk of developing Barrett’s oesophagus and oesophageal adenocarcinoma
por: Kang, James H-E, et al.
Publicado: (2018)

Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses
por: Tan, JinJing, et al.
Publicado: (2020)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma
por: Luo, Yun, et al.
Publicado: (2022)

Gender differences in the association of non-alcoholic fatty liver disease and metabolic syndrome with erosive oesophagitis: a cross-sectional study in a Taiwanese population
por: Hung, Wei-Chieh, et al.
Publicado: (2016)

Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas
por: Soldes, O S, et al.
Publicado: (1999)

Computational modelling suggests that Barrett’s oesophagus may be the precursor of all oesophageal adenocarcinomas
por: Curtius, Kit, et al.
Publicado: (2021)

Single-centre, single-blinded, randomised, parallel group, feasibility study protocol investigating if mandibular advancement device treatment for obstructive sleep apnoea can reduce nocturnal gastro-oesophageal reflux (MAD-Reflux trial)
por: O'Toole, Saoirse, et al.
Publicado: (2023)

Complex structural rearrangements are present in high-grade dysplastic Barrett’s oesophagus samples
por: Newell, Felicity, et al.
Publicado: (2019)

Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma
por: Matsuzaki, Juntaro, et al.
Publicado: (2017)

Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
por: Tang, Liping, et al.
Publicado: (2021)

Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett’s esophagus
por: Pinto, Rita, et al.
Publicado: (2022)

Pair-wise comparison analysis of differential expression of mRNAs in early and advanced stage primary colorectal adenocarcinomas
por: Lau, Tze Pheng, et al.
Publicado: (2014)

Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: study protocol for a multicentre randomised controlled trial
por: Pan, Shutao, et al.
Publicado: (2022)

Prediction models for the survival in patients with intestinal-type gastric adenocarcinoma: a retrospective cohort study based on the SEER database
por: Hong, Jiawen, et al.
Publicado: (2023)

Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus
por: Lavery, Danielle L, et al.
Publicado: (2016)

Systematic review with meta‐analysis: the effects of family history on the risk of Barrett's oesophagus and oesophageal adenocarcinoma
por: Peters, Yonne, et al.
Publicado: (2021)

Barrett’s oesophagus and oesophageal cancer following oesophageal atresia repair: a systematic review
por: Tullie, L, et al.
Publicado: (2021)

Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial
por: Thomas, Martin Geoffrey, et al.
Publicado: (2019)

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
por: Gharahkhani, Puya, et al.
Publicado: (2016)

Direct Mucosal-Side Fibrosis Cutting for Salvage Endoscopic Submucosal Dissection of Secondary Barrett's Neoplasia Adjacent Multiband Resection Scars
por: Zimmer, Vincent, et al.
Publicado: (2022)

Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees
por: Al Bakir, Ibrahim, et al.
Publicado: (2019)

Application of a multi‐gene next‐generation sequencing panel to a non‐invasive oesophageal cell‐sampling device to diagnose dysplastic Barrett's oesophagus
por: Katz‐Summercorn, Annalise, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hf7je6o5d1flei775tp8jia9dh